HLA-DR/RFLP compatible corneal grafts.
Fifty-one elective high risk transplantations were matched according to HLA/DR antigens and RFLP-subtypes. The 18 months survival of the grafts are 93% in the matched group compared to 50% in a non-matched compatible historical control group.